ClinVar Miner

Submissions for variant NM_000388.4(CASR):c.470T>C (p.Leu157Pro)

dbSNP: rs1553766286
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Athena Diagnostics Inc RCV003482264 SCV000612671 uncertain significance not provided 2022-09-27 criteria provided, single submitter clinical testing Available data are insufficient to determine the clinical significance of the variant at this time. This variant has not been reported in large, multi-ethnic general populations. (http://gnomad.broadinstitute.org) Computational tools predict that this variant is damaging.
Ambry Genetics RCV002341206 SCV002635849 uncertain significance Inborn genetic diseases; Nephrolithiasis/nephrocalcinosis 2022-06-20 criteria provided, single submitter clinical testing The p.L157P variant (also known as c.470T>C), located in coding exon 2 of the CASR gene, results from a T to C substitution at nucleotide position 470. The leucine at codon 157 is replaced by proline, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.